A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis
Public ClinicalTrials.gov record NCT05153148. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Subjects With Active Psoriatic Arthritis
Study identification
- NCT ID
- NCT05153148
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 305 participants
Conditions and interventions
Conditions
Interventions
- NDI-034858 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 5, 2022
- Primary completion
- May 3, 2023
- Completion
- Jun 1, 2023
- Last update posted
- May 30, 2024
2022 – 2023
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nimbus site #XYZ | Palm Desert | California | 92260 | — |
| Nimbus site #XYZ | Upland | California | 91786 | — |
| Nimbus site #XYZ | Hollywood | Florida | 33024 | — |
| Nimbus site #XYZ | Plantation | Florida | 33324 | — |
| Nimbus site #XYZ | St. Petersburg | Florida | 33705 | — |
| Nimbus site #XYZ | Tampa | Florida | 33613 | — |
| Nimbus site #XYZ | Tampa | Florida | 33614 | — |
| Nimbus site #XYZ | Winter Park | Florida | 32789 | — |
| Nimbus site #XYZ | Zephyrhills | Florida | 33542 | — |
| Nimbus site #XYZ | Indianapolis | Indiana | 46250 | — |
| Nimbus site #XYZ | West Des Moines | Iowa | 50265 | — |
| Nimbus site #XYZ | Lake Charles | Louisiana | 70605 | — |
| Nimbus site #XYZ | Worcester | Massachusetts | 01605 | — |
| Nimbus site #XYZ | Albuquerque | New Mexico | 87102 | — |
| Nimbus site #XYZ | Charlotte | North Carolina | 28210 | — |
| Nimbus site #XYZ | Duncansville | Pennsylvania | 16635 | — |
| Nimbus site #XYZ | Columbia | South Carolina | 29204 | — |
| Nimbus site #XYZ | Jackson | Tennessee | 38305 | — |
| Nimbus site #XYZ | Baytown | Texas | 77521 | — |
| Nimbus site #XYZ | Corpus Christi | Texas | 78404 | — |
| Nimbus site #XYZ | Houston | Texas | 77089 | — |
| Nimbus site #XYZ | Mesquite | Texas | 75150 | — |
| Nimbus site #XYZ | Beckley | West Virginia | 25801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05153148, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2024 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05153148 live on ClinicalTrials.gov.